معرفی
Christopher C. Benz is a Professor at the University of California, San Francisco, with extensive expertise in oncology and breast cancer research. His work focuses on molecular mechanisms of cancer development, biomarker discovery, and therapeutic strategies.
Education:
- University of California, Los Angeles: B.S. in Biochemistry (1968)
- University of Michigan, Ann Arbor: M.D. in Medicine (1972)
- VGH/CCABC & UBC, Vancouver: Residency in Internal Medicine/Hematology-Oncology (1972-1978)
- Yale University School of Medicine: Fellowship in Oncology (1978-1979)
Research Focus: Dr. Benz's interdisciplinary research integrates cancer genomics, molecular biology, and clinical oncology. He investigates breast cancer heterogeneity, tumor microenvironment interactions, metabolic vulnerabilities, and hormone receptor signaling. His TCGA contributions established foundational pan-cancer molecular classifications, while clinical studies focus on risk prediction models and long-term therapeutic outcomes.
Publication Trends: Recent work demonstrates a strong emphasis on translational applications, including biomarker validation (e.g., ERpS294, IGF1R variants), therapeutic targeting of metabolic enzymes (proline dehydrogenase) and cell-cycle regulators (CDK2), and characterization of tumor-adjacent tissues. Studies frequently leverage large consortia data (TCGA, STO Trialists Group) to explore molecular subtypes and survival implications.
